DK516585A - Sv40-ekspressionsvektor indeholdende hbxag-som ekspressionsmarkaer - Google Patents

Sv40-ekspressionsvektor indeholdende hbxag-som ekspressionsmarkaer Download PDF

Info

Publication number
DK516585A
DK516585A DK516585A DK516585A DK516585A DK 516585 A DK516585 A DK 516585A DK 516585 A DK516585 A DK 516585A DK 516585 A DK516585 A DK 516585A DK 516585 A DK516585 A DK 516585A
Authority
DK
Denmark
Prior art keywords
expression
hbxag
vector containing
marks
expression vector
Prior art date
Application number
DK516585A
Other languages
English (en)
Other versions
DK516585D0 (da
DK175364B1 (da
Inventor
Ann M Moriarty
Hannah Alexander
Richard A Lerner
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of DK516585D0 publication Critical patent/DK516585D0/da
Publication of DK516585A publication Critical patent/DK516585A/da
Application granted granted Critical
Publication of DK175364B1 publication Critical patent/DK175364B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/082—Hepadnaviridae (F), e.g. hepatitis B virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/223—Hepatitis related

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Image Generation (AREA)
  • Transmission And Conversion Of Sensor Element Output (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Editing Of Facsimile Originals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK198505165A 1984-03-08 1985-11-08 Antigent syntetisk peptid, antigen polymer samt receptormolekyle DK175364B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US58757084A 1984-03-08 1984-03-08
US58757084 1984-03-08
US06/648,142 US4777240A (en) 1984-03-08 1984-09-07 SV40 expression vector containing HBxAg as an expression marker
US64814284 1984-09-07
US8500359 1985-03-06
PCT/US1985/000359 WO1985003950A1 (en) 1984-03-08 1985-03-06 A sv40 expression vector containing hbxag as an expression marker

Publications (3)

Publication Number Publication Date
DK516585D0 DK516585D0 (da) 1985-11-08
DK516585A true DK516585A (da) 1985-11-08
DK175364B1 DK175364B1 (da) 2004-09-13

Family

ID=27080076

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198505165A DK175364B1 (da) 1984-03-08 1985-11-08 Antigent syntetisk peptid, antigen polymer samt receptormolekyle

Country Status (13)

Country Link
US (3) US4777240A (da)
EP (1) EP0155147B1 (da)
JP (1) JPH0832721B2 (da)
AT (1) ATE59185T1 (da)
AU (1) AU594642B2 (da)
CA (1) CA1340732C (da)
DE (1) DE3580927D1 (da)
DK (1) DK175364B1 (da)
FI (1) FI86585C (da)
IL (1) IL74544A (da)
NO (1) NO172394C (da)
NZ (1) NZ211357A (da)
WO (1) WO1985003950A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4777240A (en) * 1984-03-08 1988-10-11 Scripps Clinic And Research Foundation SV40 expression vector containing HBxAg as an expression marker
US4942125A (en) * 1984-09-07 1990-07-17 Scripps Clinic And Research Foundation SV40 expression vector containing HBxAg as an expression marker
JPS63167797A (ja) * 1985-12-18 1988-07-11 マイクロジエネシス，インコ−ポレイテイド 選択された昆虫宿主細胞中で選択されたポリペプチドを製造する方法
US4816564A (en) * 1986-01-31 1989-03-28 Merck & Co., Inc. Method for producing hepatitis B virus proteins in yeast
EP0300213A1 (en) * 1987-06-22 1989-01-25 Hexal-Pharma Gentechnik GmbH & Co. KG Hepatitis a viral peptide particle immunogens
WO1989004964A1 (en) * 1987-11-16 1989-06-01 Fox Chase Cancer Center Determination of anti-pol as an early marker or viral hepatitis infection
JPH0260589A (ja) * 1988-08-26 1990-03-01 Natl Sci Council バクテリオファージｍ１３の遺伝子□ｄ２プロモーターを使用した大腸菌中での外来タンパクの高レベル産生
US5650275A (en) * 1990-06-11 1997-07-22 Nexstar Pharmacueticals Inc Target detection method using spectroscopically detectable nucleic acid ligands
EP0491077A1 (en) * 1990-12-19 1992-06-24 Medeva Holdings B.V. A composition used as a therapeutic agent against chronic viral hepatic diseases
US6297048B1 (en) * 1992-02-04 2001-10-02 Chiron Corporation Hepatitis therapeutics
US5378605A (en) * 1993-06-08 1995-01-03 Thomas Jefferson University Method of detecting hepatitis B variants having deletions within the X region of the virus genome
US5872206A (en) * 1994-10-06 1999-02-16 The General Hospital Corporation Compositions and methods for interfering wtih hepatitis B virus infection
WO1999036434A1 (en) * 1998-01-19 1999-07-22 Mogam Biotechnology Research Institute Liposomes comprising peptide antigens derived from x protein of hepatitis b virus
WO1999039200A1 (en) * 1998-01-29 1999-08-05 Thomas Jefferson University Molecular markers for diagnosing hepatocellular carcinoma
US6593289B1 (en) 2002-01-15 2003-07-15 Milliken & Co. Liquid fabric softener formulations comprising hemicyanine red colorants
US6638903B2 (en) 2002-01-15 2003-10-28 Milliken & Company Non-staining red colorants and liquid fabric softener formulations comprising such non-staining colorants
JP4777984B2 (ja) 2004-07-13 2011-09-21 パンドウィット・コーポレーション フレキシブルプリント回路板を備えた通信コネクタ
ATE537586T1 (de) 2005-07-15 2011-12-15 Panduit Corp Kommunikationsverbinder mit einer vorrichtung zur kompensation von uebersprechen
WO2007110098A1 (en) * 2006-03-29 2007-10-04 Institut National De La Sante Et De La Recherche Medicale HBx PEPTIDES, CAPABLE OF ELICITING A PROMISCUOUS IMMUNODOMINANT CD4+ RESPONSE DIRECTED AGAINST HBV
NZ586074A (en) * 2010-06-10 2013-07-26 Auckland Uniservices Ltd LCLRP peptides, constructs and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) * 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
US4415491A (en) * 1980-01-14 1983-11-15 The Regents Of The University Of California Synthetic vaccine peptide epitomes of hepatitis B surface antigen
US4338397A (en) 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
FI83662C (fi) * 1980-07-17 1991-08-12 Scripps Clinic Res Diagnostik antikropp och foerfarande foer dess framstaellning.
ZW18282A1 (en) * 1981-08-31 1983-03-23 Genentech Inc Preparation of polypeptides in vertebrate cell culture
US4442205A (en) * 1981-09-22 1984-04-10 The United States Of America As Represented By The Department Of Health And Human Services Simian virus recombinant that directs the synthesis of hepatitis B surface antigen
US4459359A (en) * 1981-11-19 1984-07-10 New York Blood Center, Inc. Sensitive immunoassays of antigens or antibodies sequestered within immune complexes
JPS5936698A (ja) * 1982-08-20 1984-02-28 Science & Tech Agency Ｂ型肝炎ウイルス遺伝子を組込んだ組換えｄｎａおよび形質転換動物細胞
US4777240A (en) * 1984-03-08 1988-10-11 Scripps Clinic And Research Foundation SV40 expression vector containing HBxAg as an expression marker
US4942125A (en) * 1984-09-07 1990-07-17 Scripps Clinic And Research Foundation SV40 expression vector containing HBxAg as an expression marker
US4895800A (en) * 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen

Also Published As

Publication number Publication date
DK516585D0 (da) 1985-11-08
DK175364B1 (da) 2004-09-13
EP0155147B1 (en) 1990-12-19
NZ211357A (en) 1988-08-30
NO172394C (no) 1993-07-14
JPS61502094A (ja) 1986-09-25
FI86585B (fi) 1992-05-29
IL74544A (en) 1994-11-11
AU594642B2 (en) 1990-03-15
WO1985003950A1 (en) 1985-09-12
US5183734A (en) 1993-02-02
US5534405A (en) 1996-07-09
DE3580927D1 (de) 1991-01-31
ATE59185T1 (de) 1991-01-15
NO172394B (no) 1993-04-05
EP0155147A3 (en) 1985-11-06
CA1340732C (en) 1999-09-14
IL74544A0 (en) 1985-06-30
EP0155147A2 (en) 1985-09-18
FI854395L (fi) 1985-11-07
FI854395A0 (fi) 1985-11-07
NO854448L (no) 1986-01-06
JPH0832721B2 (ja) 1996-03-29
US4777240A (en) 1988-10-11
FI86585C (fi) 1992-09-10
AU4067285A (en) 1985-09-24

Similar Documents

Publication Publication Date Title
DK516585A (da) Sv40-ekspressionsvektor indeholdende hbxag-som ekspressionsmarkaer
DE2963973D1 (en) Method and reagent for the quantitative determination of hydrogen peroxide
EP0244234A3 (en) Transformation of trichoderma
ES2038148T3 (es) Preparaciones cosmeticas.
ES2086383T3 (es) Deteccion de cepas fungicas mutantes.
BG50281A3 (bg) Метод за получаване на рекомбинантн днк експресионен вектор
DE3585049D1 (de) Monoklonale antikoerper.
NO872952D0 (no) Katode for bruk i hydrogenutviklende elektrokjemiske prosesser, samt fremgangsmaate til fremstilling av katoden.
ES8800725A1 (es) Un procedimiento para producir un anticuerpo monoclonal
AU527196B2 (en) Enzymatic method for detecting cancer in mammalian tissue
DK203588D0 (da) Fremgangsmaade til fremstilling af proteiner
GB2183674B (en) Microcarrier for cell culture.
DE59010897D1 (de) Expressionsvektoren zur Synthese von Proteinen in der Spalthefe Schizosaccharomyces pombe
FI821921A7 (fi) Hybridivektori, menetelmä hybridivektoreiden amplifikaation ja ekspression parantamiseksi mitokomitokondriaperäisen DNA:n käytön avulla.
DK302785A (da) Monoklonale antistoffer overfor humant interferon-gamma, hybridcellelinier, der frembringer disse antistoffer, antistoffernes anvendelse og fremgangsmaader til fremstilling deraf
SU1264575A1 (ru) Способ иммобилизации клеток
SU871552A1 (ru) Устройство для электрохимической обработки длинномерных изделий микронных толщин
DE69314633D1 (de) Methoden und Zusammensetzungen um die Sensitivität eine Zellegegen DNA-Zerstörende Agentien zu erhöhen
SU770389A1 (ru) Способ определения положения управляющего органа ядерного реактора
JPS5340585A (en) Method and reagent for quantitating hydrogen peroxide
SU811519A1 (ru) Способ получения белкового раствора
David Michel Foucault on the Wreck of Leviathan and the Constitution of a New Stylistics of Love
RO89232A2 (ro) Procedeu de concentrare a unor dispersii de polimeri
SU1182881A1 (ru) Способ активационного анализа
AU2249077A (en) Online amperometric analysis system and method incorporating automatic flow compensation

Legal Events

Date Code Title Description
PUP Patent expired